spieropbouw bij ouderdom muscle loss sarcopenia
Conditions
Interventions
At 02.00 h, half of the subjects will receive a bolus of protein beverage by
their nasogastric tube. The same protein as has been used previously [MEC
07-3-086], will be used in this study. Subjects
Sponsors
Universiteit Maastricht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Male 65-80 yr of age no medication BMI
Exclusion criteria
Exclusion criteria: Comorbidities associated with muscle metabolism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint will be muscle protein synthesis. Muscle protein synthesis will be calculated by differences in plasma and muscle tracer enrichments. Phenylalanine and tyrosine enrichment in plasma samples and in the muscle free amino acid pool will be measured using gas chromatography-mass spectrometry, while the phenylalanine enrichment in muscle proteins will be measured with GC-combustion IRMS. We measure muscle protein synthesis after nocturnal protein ingestion by nasogastric tube. | — |
Secondary
| Measure | Time frame |
|---|---|
| None. | — |
Countries
Netherlands
Outcome results
None listed